Caris Life Sciences, Inc.
CAI
Rank in Stocks
#2200
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing... Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
Share Price
$32.28
Last synced: 2026-10-21
Market Cap
$9.12B
Change (1 day)
3.76%
Change (1 year)
7.46%
Country
US
Trade Caris Life Sciences, Inc. (CAI)
Category
Healthcare
Stock price history for Caris Life Sciences, Inc. (CAI)
Highest end of day price: $29.65 on 2026-10-01
Lowest end of day price: $26.95 on 2025-06-01
Lowest end of day price: $26.95 on 2025-06-01
Stock price history of Caris Life Sciences, Inc. from 2025 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | -17.75% |
| 2025 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.17 | -4.24% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
